SANUWAVE 13G/A: Vanguard Reports 0 Shares
SANUWAVE Health Inc Schedule 13G/A: The Vanguard Group filed Amendment No. 1 reporting 0 shares and 0% beneficial ownership of SANUWAVE common stock following an internal realignment.
Rhea-AI Filing Summary
SANUWAVE Health Inc Schedule 13G/A: The Vanguard Group filed Amendment No. 1 reporting 0 shares and 0% beneficial ownership of SANUWAVE common stock following an internal realignment. The filing states this change is "in accordance with SEC Release No. 34-39538 (January 12, 1998)." The amendment is signed by Ashley Grim on 03/27/2026.
Positive
- None.
Negative
- None.
Insights
Vanguard reports no beneficial ownership of SANUWAVE after internal disaggregation.
The filing documents an internal realignment at The Vanguard Group that led certain subsidiaries or business divisions to report holdings separately, and states Vanguard no longer is deemed to beneficially own the securities held by those units, citing SEC Release No. 34-39538.
Practical implications depend on the underlying subsidiaries' separate filings; subsequent Schedule 13G/A or 13D/13G entries from those entities may show beneficial positions. Cash-flow treatment and any trading intent are not addressed in this excerpt.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the SANUWAVE (SNWV) Schedule 13G/A filing show?
Why did Vanguard report 0% ownership for SNWV?
Who signed the SANUWAVE Schedule 13G/A amendment for Vanguard?
Where can I find the subsidiaries' SANUWAVE holdings after the realignment?
AI-generated analysis. How Rhea-AI works. Not financial advice.